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Background and Objective: The misuse of antibiotics is not a harmless practice; rather, it can 
render future antibiotic treatments ineffective. This study looked to determine patient knowledge 
and perception of upper respiratory infections and indicated treatment.
Methods: The authors developed and administered a questionnaire to 98 patients visiting afﬁ  li-
ated family medicine clinical sites. Participants were selected randomly, either while sitting in 
the waiting room, or after being seen by the clinician.
Results: While more than half the respondents recognized that treatment for colds did not require 
antibiotics, 70% erroneously indicated that viruses require antibiotic treatment. Additionally, 
almost 90% of respondents thought that yellow nasal discharge or coughing up yellow mucous 
requires antibiotic treatment. It was interesting to note that 95% of patients reported satisfaction 
when advised by their physician that antibiotic treatment wasn’t necessary, even if they initially 
thought they needed antibiotics.
Conclusions: Primary care providers have the greatest opportunity to curb inappropriate anti-
biotic use by both prescribing appropriately and educating their patients about proper antibiotic 
use when indicated.
Keywords: antibiotic resistance, antibiotic indications, upper respiratory infection, patient 
knowledge, patient education
Background
Although the discovery of penicillin has greatly changed the course of modern medi-
cine, its exploitation along with many other antibiotics has resulted in antimicrobial 
resistance. Despite early warnings of resistance, antibiotic misuse and overuse con-
tinues. Beginning in the early 1990’s the scientiﬁ  c community warned of the problem 
of antibiotic resistance as a global hazard. Today, the literature is replete with articles 
that explain why resistance occurs, the magnitude of the problem, and various solutions 
and interventions. While studies clearly support that drug resistance has been linked to 
the overuse of antibiotics including broad-spectrum antibiotics, inappropriate dosing, 
and antibiotics with unfavorable pharmacodynamics and pharmacokinetics, clinicians 
often argue that patient expectations have also exacerbated the problem (Britten 1995; 
Britten and Ukoumunne 1997; Macfarlane et al 1997; Mangione-Smith et al 1999; 
Hooton and Levy 2001; Scott et al 2001). A decade of extensive research initiatives 
(Ware 2000; Gonzales et al 2001a), a national Centers for Disease Control and Preven-
tion (CDC) campaign targeting inappropriate consumer usage of antibiotics, specialty 
college guidelines (Brooks et al 2000; Gonzales et al 2001a; Snow et al 2001; CDC 
2007), and increased use of the pneumococcal vaccine are beginning to decrease the 
burden of overall antiobiotic selective pressure (Hooton and Levy 2001; Finkelstein 
et al 2003). However, antiobiotic resistance continues to be detrimental to the delivery 
of effective healthcare in the United States (Yates 1999; Jacobs et al 2003).Patient Preferences and Adherence 2008:(2) 36
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Nearly 90% of all upper respiratory infections are caused 
by viruses (Larrabee 2002; Brunton and Pichichero 2006), 
which do not respond to antibiotic treatment. Nevertheless, 
antibiotics are widely prescribed for these conditions. This 
misuse of antibiotics is not a harmless practice. Rather, it 
“creates a selective pressure for the development of resis-
tant strains of pathogens” (Larrabee 2002), which leads to 
the ineffectiveness of future antibiotic use. An example has 
been the extensive over prescribing of the second generation 
macrolide antibiotics, which experts clearly argue has been 
the overwhelming cause of macrolide resistance in the past 
10 to 15 years (Lonks et al 2002; Moellering et al 2002; 
Jacobs et al 2003; Doern 2005; Doern et al 2005; Vanderkooi 
et al 2005). This example has signiﬁ  cantly complicated 
the effective treatment of community-acquired respiratory 
tract infections such as rhinosinusitus, community acquired 
pneumonia, otitis media, and acute exacerbation of chronic 
bronchitis. In fact, roughly 30% of the pneumococcal strains 
common to all these infections are resistant to penicillins 
and/or macrolides (Moellering et al 2002; Doern 2005).
Various innovative interventions targeting both patients 
and physicians have been utilized to address this growing 
concern. CDC (2007) have initiated a “Get Smart” national 
campaign, which, 1) informs patients about the differences 
between viral and bacterial infections, 2) advises patients not 
to take an antibiotic for a viral illness, 3) asks patients not 
to pressure clinicians for antibiotic therapy, and 4) cautions 
patients not to use antibiotics prescribed for another person or 
use antibiotics left over from a previous illness. Investigators 
have taken this campaign one step further. Through utiliza-
tion of the CDC campaign brochure, Pontes and colleagues 
(2005) have identified an educational intervention that 
increases consumers’ preference for physicians who chose 
not to prescribe antibiotics unnecessarily for simple upper 
respiratory tract infections. Study participants rated doctors 
more favorably when antibiotics were not prescribed for acute 
viral infections when they understood the differences between 
bacterial and viral illnesses and why inappropriate prescrib-
ing is harmful. Such a study demonstrated how a relatively 
simple educational intervention could drastically change 
patients’ beliefs about antibiotic indications and resistance. 
Other investigators (Gonzales et al 1999, 2001b, 2004, 2005; 
Yates 1999; Brooks et al 2000; Bauchner et al 2001; Snow 
et al 2001; Trepka et al 2001; Larrabee 2002; Harris et al 
2003; Taylor et al 2003; Brown and Nathwani 2005) have 
delineated possible solutions to this problem that include 
development of speciﬁ  c medical specialty treatment guide-
lines and algorithms, restricted use of antibiotics, antibiotic 
cycling, educational videos and pamphlets, and interactive 
computerized educational programs. Nevertheless, despite 
a modest decline in overall antibiotic use, patients continue 
to engage in antibiotic misuse, and clinicians continue to 
prescribe indiscriminately (Mangione-Smith et al 1999). 
Interventions that have shown some success have largely 
failed to transfer over into daily clinical practice. Continued 
research must be performed addressing the multifactorial eti-
ology of this problem that involves patients, clinicians, health 
insurance organizations, and pharmaceutical companies. At 
a minimum, continued attempts at curbing the problem of 
antibiotic resistance will rely on patient and clinician educa-
tion and speciﬁ  cally understanding and addressing patient 
preferences.
Several studies (Britten 1995; Britten and Ukoumunne 
1997; Macfarlane et al 1997; Mangione-Smith et al 1999; 
Hooton and Levy 2001; Scott et al 2001) have examined the 
correlation between patient expectation of antibiotic prescrip-
tions and practitioner prescribing behaviors, suggesting that 
perceived expectations were more likely to inﬂ  uence the deci-
sion to prescribe medication. A cause for antibiotic overuse 
is when patients expect or clinicians perceive that patients 
expect antibiotic treatment for acute infection, whether viral 
or bacterial.
Methodology
This university Institutional Review Board (IRB)-approved 
study was undertaken to determine the perception and 
knowledge of patients regarding antibiotic use in a 
family medicine practice. The investigators developed and 
administered the approved questionnaire (see Table 1) to 
100 individuals in three family medicine practices located 
in southern New Jersey. These clinical ofﬁ  ces were chosen 
due to their patient population demographics. By having 
patients from these three ofﬁ  ces participate in the study, 
the authors expected to include representation from a 
varied cultural and socioeconomic patient population 
group.
The only exclusion criterion for participation was age, 
which needed to be greater than 18. The questionnaire was 
administered to patients visiting university afﬁ  liated family 
medicine clinical sites located in southern New Jersey. Front 
desk personnel asked patients when they ﬁ  rst registering 
or after their clinician had seen them, if they would like to 
participate in this study on a voluntary basis. A study coor-
dinator completed the informed consent process with the 
participants and sat with them while they completed the ques-
tionnaire. An introductory paragraph on the questionnaire Patient Preferences and Adherence 2008:(2) 37
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advised patients about the current deﬁ  nition of respiratory 
infections as deﬁ  ned by the National Institutes of Health (NIH 
2006). Participants were offered help with completing the 
questionnaire, including reading the questions to them and 
ﬁ  lling in the answers. The ofﬁ  ce physicians were blinded to 
their patients’ study participation.
Results
One hundred surveys were completed, two of which were 
eliminated from the study results as the participants did not 
meet the age criteria. The breach of protocol to include the 
two underage participants was reported to the IRB. Table 2 
below provides further demographic descriptions of the study 
participants.
Table 3 contains a frequency distribution analysis of 
eight questions that provided signiﬁ  cant information for the 
authors. From these results, it is clear that study participants 
do not have an understanding of the differences between viral 
and bacterial etiologies of respiratory tract infections, with a 
signiﬁ  cant number of participants believing that antibiotics 
are indicated for viral infections. Additionally the presence 
of yellow mucous alone created a greater perception among 
participants that antibiotics were indicated. This may well 
be the result of clinician over emphasis on this symptom 
guiding antibiotic prescribing rather than published treat-
ment guidelines (Hooton and Levy 2001). Discouragingly, 
only half of the respondents encountered a clinician that 
would not prescribe an antibiotic even though the patient 
felt it was necessary. This again validates clinician’s beliefs 
regarding patient expectations and its subsequent effect of 
antibiotic overuse (Britten 1995; Britten and Ukoumunne 
1997; Macfarlane et al 1997; Mangione-Smith et al 1999; 
Hooton and Levy 2001; Scott et al 2001). Despite lack of 
knowledge regarding appropriate antibiotic prescribing, 
ninety-ﬁ  ve percent of participants are satisﬁ  ed with their 
clinician when told an antibiotic is not needed, clearly 
contradicting the perceptions that many clinicians have 
regarding their patients. Interestingly, a large majority of 
Table 1 Survey questions
How many times in the last year have you been on an antibiotic for treatment of a respiratory infection?
_____ times
When you get a respiratory infection, how many days do you usually wait before you seek treatment from a healthcare provider?
_____ days
Do you think that an antibiotic is necessary when you have a respiratory infection for a period of over 5 days?
Yes ____  No ____
When prescribed an antibiotic for a respiratory infection, do you take it for the number of days that your doctor prescribes for you?
Yes ____  No ____
If not, what is the main reason you do not? (ie, side effects? forget?)
When given an antibiotic for a respiratory infection, to take for 5 days, I ﬁ  nish taking all of the medication.
Yes ____  No ____
When given an antibiotic for a respiratory infection, to take for 10 days, I ﬁ  nish taking all of the medication.
Yes ____  No ____
I stop taking antibiotics when I start feeling better.
Yes ____  No ____
Do you think that some antibiotics for a respiratory infection, work better for you?
Yes ____  No ____
Have you ever requested a speciﬁ  c antibiotic by name for a respiratory infection?
Yes ____  No ____
If so, which one?
_______________________________________________________________________________________________________________
Patients with symptoms of the common cold require treatment with antibiotics
Do not agree  Slightly agree  Moderately agree  Strongly agree  Completely agree
Patients who cough up yellow or greenish mucous require antibiotics
Do not agree  Slightly agree  Moderately agree  Strongly agree  Completely agree
Patients who have yellow or greenish nasal discharge from the nose require antibiotics
Do not agree  Slightly agree  Moderately agree  Strongly agree  Completely agree
Respiratory infections caused by viruses require treatment with antibiotics
Do not agree  Slightly agree  Moderately agree  Strongly agree  Completely agree
Many antibiotics today do not work as well as they used to in the past
Do not agree  Slightly agree  Moderately agree  Strongly agree  Completely agreePatient Preferences and Adherence 2008:(2) 38
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participants wanted to be further educated on the topic of 
antibiotic resistance.
There were no signiﬁ  cant differences in patient responses 
based on gender, education, ethnic group or prescription 
plan.
Discussion
Our study demonstrates just how little patients truly under-
stand about upper respiratory tract infections, antibiotic indi-
cation, and its ramiﬁ  cations for misuse. With the morbidity 
and mortality associated with resistant bacteria, particularly 
streptococcus pneumonia, physicians need to educate patients 
not only on preventative measures (such as immunoprophy-
laxis), but also on avoidance of antibiotic misuse unless there 
is strong evidence for bacterial infection. Before this can 
occur however, clinicians themselves must avoid the common 
misperception that patients expect antibiotic treatment even 
when not indicated. If the medical community is to succeed at 
curbing the problem of antibiotic resistance, current research 
suggests that patient education is the key.
The authors recognize the small sample size and the 
geographical limitations of this study, however, a number 
of studies have recognized the importance of looking at 
local communities and health practices when planning new 
health policies or interventions (Mayster et al 1990; Hubbell 
1991). The results of such community-oriented research 
might provide additional information not evident in national 
research studies, such as was shown in our study where 
patients trust their physician and are satisﬁ  ed when told 
antibiotic treatment is not indicated and their preference for 
being educated by their physicians about speciﬁ  c antibiotic 
treatment options.
Primary care providers need to take advantage of this 
opportunity, reﬂ  ect on both their own prescribing habits 
and beliefs, and on their patients’ health care preferences 
and thereby improve patient education regarding antibiotic 
resistance. Furthermore, academic institutions should place 
strong emphasis on patient education in their medical cur-
ricula, training all future physicians to effectively counsel 
their patients regarding necessary and/or unnecessary 
treatment.
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